Coronavirus: the Government published a report with data on the safety of vaccines and adverse effects

The National Vaccine Safety Commission (Conaseva) published a new report, after three months, which includes for the first time all people from 3 years of age onwards

The Ministry of Health https://social.artisanssoft.com/read-blog/32593_livepros-capsulas-para-que-sirve.html revealed today the data on the safety of the vaccines against the Covid-19 coronavirus that were applied during the https://www.reusealways.com/read-blog/106810_livepros-capsulas-para-que-sirve.html first 13 months of the campaign in the country and, of 40 million people inoculated, 60,000 had adverse effects and are https://socialrus.com/story10107275/livepros-capsulas-para-que-sirve investigated four deaths. Until January 31, 2022, 88,232,021 doses of vaccines were applied to 40,174,564 people in Argentina, and https://catbuzzy.com/read-blog/80811_livepros-capsulas-para-que-sirve.html the global rate of notification of Events Supposedly Attributable to Vaccination and Immunizations (Esavi) was 67.8 per 100,000doses administered.

According to the 17th https://jav.social/hunterandersons vaccine safety surveillance report, prepared in conjunction with the National Vaccine Safety Commission (Conaseva), https://www.kemovebbs.com/Thread-Livepros-Capsulas-para-que-sirve 59,797 events have been reported in the country, where more than 96 percent of the cases were mild to moderate and https://murl.com/2vLwM the most common were: fever, headache, weakness, pain or reaction at the injection site, and mild allergy. Esavi is https://www.evernote.com/shard/s389/sh/edd3b679-e744-cc64-168b-bfdd1b5f8f87/c0831d448e935bbea6fe38902a5b84d0 defined as any unexpected health situation (unfavorable or unintentional symptoms or signs, abnormal laboratory finding) that occurs https://trello.com/c/hCnkvrJt/1-livepros-capsulas-powerful-prostatitis-capsules-with-long-lasting-results after vaccination and that does not necessarily have a causal relationship with the vaccination or with the biological product.

In the case of vaccination https://quasar-meerkat-2bf.notion.site/Livepros-Capsulas-para-que-sirve-Men-s-Prostate-Sleep-Support-Formula-22cd6c405ac0427fa77ad72634f1577a against the coronavirus, as it was carried out with drugs that had emergency approval, vigilance was extreme at the start of the https://app.simplenote.com/p/JS77zn vaccination campaign. This is reflected in the fact that 70% of the almost 60,000 Esavi were reported in the first three months http://ownersillustrated.com/profiles/blogs/livepros-capsulas-para-que-sirve of the campaign , when the sensitivity of the surveillance system is very high in the face of the introduction of new vaccines.

In the 11-page document , http://stationfm.ning.com/profiles/blogs/livepros-capsulas-para-que-sirve the specialists also indicated that 69.9% of the reported ESAVIs were made by women and the average age, between both sexes, https://www.katkoute.com/social/hunterandersons was 41.5 years . “This profile could be related to the fact that most of the events were reported at the beginning of the https://www.geeb.xyz/hunterandersons campaign that included health personnel. The Sputnik V vaccination was the first to be implemented in Argentina, starting https://www.vevioz.com/read-blog/54565_livepros-capsulas-para-que-sirve.html the National Campaign on December 29, 2020, and it was the most used at the beginning of the campaign. It is expected that the sensitivity of the https://www.b-webdesign.org/dir-wowonder/read-blog/48345_livepros-capsulas-para-que-sirve.html surveillance system will be very high at the beginning of the vaccination campaigns with the introduction of new vaccines”, they argued from Conaseva in the document.

When analyzing the events https://www.connectyu.com/1649934141620079_13546 classified as related (A1) in people aged 3 years and over, it is evident that fever, headache accompanied by myalgias and https://www.justyari.com/read-blog/70355_livepros-capsulas-para-que-sirve.html arthralgias are the most frequent diagnoses. Ten events with a diagnosis of thrombosis syndrome with thrombocytopenia according https://www.camfect.com/read-blog/8891_livepros-capsulas-para-que-sirve.html to the Brighton Collaboration definition were analyzed and classified by Conaseva as indeterminate B1 events , according https://7smabu.com/read-blog/80126_livepros-capsulas-para-que-sirve.html to the WHO classification. One event was classified as indeterminate B2.Four of these events had a fatal outcome. The events under https://kaalama.org/read-blog/95105 analysis are cases under follow-up by the National Vaccine Safety Commission, which are still under study to close their final classification, https://mayempire.com/read-blog/35146_livepros-capsulas-para-que-sirve.html ”the commission described in one of the last paragraphs of the report, in which it is not detailed which vaccine the four people who died had received.

Consulted by LA NACION, https://www.promorapid.com/read-blog/119532_livepros-capsulas-para-que-sirve.html Eduardo López, an infectious disease doctor and head of the Department of Medicine at the Ricardo Gutiérrez Children's Hospital, analyzed https://ussv.club/read-blog/52336_livepros-capsulas-para-que-sirve.html the new report and stressed that some data are correct and coincide with what is reported in other countries, but he was surprised by the decision. https://corosocial.com/read-blog/82938_livepros-capsulas-para-que-sirve.html official decision not to relate directly to the vaccines some conditions that the drug manufacturers themselves had already reported could occur.

https://dailylivebreakingnews.blogspot.com/2022/04/hard-protest-of-meps-for-political-tone.html

“I am surprised that conditions such as thrombosis with thrombocytopenia syndrome, for Sputnik and AstraZeneca or myocarditis for vaccines such as Pfizer and Moderna that have the same technology, the commission classifies them as “indeterminate” and not as related, which is what it should happen".

When asked if the reported Esavi percentages are within international parameters, López said yes and remarked: “The serious adverse effects are low. This shows that the vaccines are safe. The report also identifies more Esavi in ​​women, but I think it is because they are more meticulous and tend to better identify changes and report them.

The end of the third wave

On the other hand, the Ministry of Health also indicated that with more than 80 percent of the population vaccinated with a complete schedule, Argentina registered a pronounced decrease in the number of Covid-19 cases for the eleventh consecutive week, since the last week showed a drop of 99.41 percent compared to the maximum peak of the pandemic in January with more than 800,000 infected.

Besides,As of April 12, a total of 39,421 active cases were registered, representing 0.43%of the total cases registered to date (9,049,250). Regarding intensive care beds, it stands at 37.3% at the national level and 39% in the AMBA metropolitan region.

Likewise, the number of people hospitalized in intensive care for Covid-19 registered 10 percent less than the previous week.